PharmaEssentia Corporation (LUX:261280558)
16.80
-0.20 (-1.18%)
At close: Oct 14, 2025
PharmaEssentia Revenue
PharmaEssentia had revenue of 3.60B TWD in the quarter ending June 30, 2025, with 56.19% growth. This brings the company's revenue in the last twelve months to 12.63B, up 82.77% year-over-year. In the year 2024, PharmaEssentia had annual revenue of 9.73B with 90.67% growth.
Revenue (ttm)
12.63B TWD
Revenue Growth
+82.77%
P/S Ratio
14.15
Revenue / Employee
96.45M TWD
Employees
131
Market Cap
5.20B EUR
Revenue Chart
* This company reports financials in TWD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.73B | 4.63B | 90.67% |
| Dec 31, 2023 | 5.11B | 2.22B | 77.15% |
| Dec 31, 2022 | 2.88B | 2.23B | 339.00% |
| Dec 31, 2021 | 656.51M | 99.25M | 17.81% |
| Dec 31, 2020 | 557.26M | 251.57M | 82.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reinet Investments S.C.A. | 798.00M |
| Socfinaf | 663.01M |
| Socfinasia | 199.82M |
| CPI FIM | 182.41M |
| Luxempart | 97.19M |
| Fotex Holding S.E. | 42.87M |
| Velcan Holdings | 2.95M |